Cargando…

Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience

We report our single center experience with the use of basiliximab, a chimeric monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor (CD25), in combination with a steroid- and tacrolimus-based regimen in adult to adult living-related liver transplantation (ALRLT)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruttadauria, S, Mandalà, L, Biondo, D, Spampinato, M, Lamonaca, V, Volpes, R, Vizzini, G, Marsh, JW, Marcos, A, Gridelli, B
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721340/ https://www.ncbi.nlm.nih.gov/pubmed/19707350

Ejemplares similares

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
por: Gundlapalli, S., et al.
Publicado: (2013)

Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report
por: Chen, Tingting, et al.
Publicado: (2022)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
por: Kim, Ha Eun, et al.
Publicado: (2021)

Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab
por: Anzivino, Elena, et al.
Publicado: (2011)

Single Balloon Enteroscopy for Endoscopic Retrograde Cholangiography in a Patient with Hepaticojejunostomy after Liver Transplant
por: Di Pisa, Marta, et al.
Publicado: (2010)

Mechanism of cellular rejection in transplantation
por: Ingulli, Elizabeth
Publicado: (2010)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
por: Ijiri, Naohiro, et al.
Publicado: (2022)

Outcome Comparison between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation
por: Kim, Sang Jin, et al.
Publicado: (2020)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Acute cellular rejection in lung transplantation
por: Manyeruke, F, et al.
Publicado: (2019)

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
por: Koch, Martina, et al.
Publicado: (2009)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients
por: Masset, Christophe, et al.
Publicado: (2023)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients
por: Kamar, Nassim, et al.
Publicado: (2020)

The Effect of Monthly Anti-CD25(+) Treatment with Basiliximab on the Progression of Chronic Renal Dysfunction after Lung Transplantation
por: Ross, D. J., et al.
Publicado: (2020)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction
por: Weissenbacher, Annemarie, et al.
Publicado: (2015)

Neutrophil-to-lymphocyte ratio predicts early acute cellular rejection in living donor liver transplantation
por: Lee, Boram, et al.
Publicado: (2020)

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database
por: Ali, Hatem, et al.
Publicado: (2023)

Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
por: López-Abente, Jacobo, et al.
Publicado: (2021)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

Surveillance for acute cellular rejection after lung transplantation
por: Greer, Mark, et al.
Publicado: (2020)

Failing Heart Transplants and Rejection—A Cellular Perspective
por: Hurskainen, Maria, et al.
Publicado: (2021)

Case reports: combination therapy with proteasome inhibitor Bortezomib and humanized anti-CD25 Basiliximab for treatment of adult T cell leukaemia lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2014)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Basiliximab/steroids/tacrolimus: Pneumonia with Scedosporium apiospermum and Lomentospora prolificans: case report
Publicado: (2021)

Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.
por: El-Meteini, Mahmoud, et al.
Publicado: (2014)

Continuous Renal Replacement Therapy after Liver Transplantation: Peri-Operative Associated Factors and Impact on Survival
por: Martucci, Gennaro, et al.
Publicado: (2022)

Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018)

Direct‐acting antivirals ability to clear intestinal HCV‐RNA in liver transplant patients
por: Pietrosi, Giada, et al.
Publicado: (2020)

Antibody-mediated rejection after adult living-donor liver transplantation triggered by positive lymphocyte cross-match combination
por: Hori, Tomohide, et al.
Publicado: (2012)

Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
por: Ajlan, Aziza, et al.
Publicado: (2021)

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
por: Huang, Zhenli, et al.
Publicado: (2022)

Cellular Mechanisms of Rejection of Optic and Sciatic Nerve Transplants: An Observational Study
por: Yonar, Merve, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qdk1svcmdqnfgiju0stegpo3cr